Counterfeit medication is a serious issue, with millions of seized pills mimicking prescription opioids. The DSCSA requires serialized data tracking to combat this, but delays in EPCIS data and manufacturing compliance pose challenges. Early adoption benefits include better drug safety and supply chain efficiency. To prepare for the November deadline, facilities should train staff on data scanning and verify their GLN and GCP. Starting now is essential for compliance and optimizing operations.